150 related articles for article (PubMed ID: 35426792)
1. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
[TBL] [Abstract][Full Text] [Related]
2. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
[TBL] [Abstract][Full Text] [Related]
3. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
Evans DG; Brentnall A; Byers H; Harkness E; Stavrinos P; Howell A; ; Newman WG; Cuzick J
J Med Genet; 2017 Feb; 54(2):111-113. PubMed ID: 27794048
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
5. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
Vachon CM; Scott CG; Tamimi RM; Thompson DJ; Fasching PA; Stone J; Southey MC; Winham S; Lindström S; Lilyquist J; Giles GG; Milne RL; MacInnis RJ; Baglietto L; Li J; Czene K; Bolla MK; Wang Q; Dennis J; Haeberle L; Eriksson M; Kraft P; Luben R; Wareham N; Olson JE; Norman A; Polley EC; Maskarinec G; Le Marchand L; Haiman CA; Hopper JL; Couch FJ; Easton DF; Hall P; Chatterjee N; Garcia-Closas M
Breast Cancer Res; 2019 May; 21(1):68. PubMed ID: 31118087
[TBL] [Abstract][Full Text] [Related]
6. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
[TBL] [Abstract][Full Text] [Related]
8. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
[TBL] [Abstract][Full Text] [Related]
9. Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses.
Holowko N; Eriksson M; Kuja-Halkola R; Azam S; He W; Hall P; Czene K
Cancer Res; 2020 Apr; 80(7):1590-1600. PubMed ID: 32241951
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Breast Cancer Risk Assessment for
Gallagher S; Hughes E; Kurian AW; Domchek SM; Garber J; Probst B; Morris B; Tshiaba P; Meek S; Rosenthal E; Roa B; Slavin TP; Wagner S; Weitzel J; Gutin A; Lanchbury JS; Robson M
JCO Precis Oncol; 2021 Jun; 5():. PubMed ID: 34322652
[TBL] [Abstract][Full Text] [Related]
11. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
Roberts E; van Veen EM; Byers H; Barnett-Griness O; Gronich N; Lejbkowicz F; Pinchev M; Smith MJ; Howell A; Newman WG; Woodward ER; Harkness EF; Brentnall AR; Cuzick J; Rennert G; Howell SJ; Evans DG
Genet Med; 2023 Sep; 25(9):100846. PubMed ID: 37061873
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
[TBL] [Abstract][Full Text] [Related]
14. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
[TBL] [Abstract][Full Text] [Related]
15. Extended gene panel testing in lobular breast cancer.
van Veen EM; Evans DG; Harkness EF; Byers HJ; Ellingford JM; Woodward ER; Bowers NL; Wallace AJ; Howell SJ; Howell A; Lalloo F; Newman WG; Smith MJ
Fam Cancer; 2022 Apr; 21(2):129-136. PubMed ID: 33763779
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
[TBL] [Abstract][Full Text] [Related]
17. Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population.
Senda N; Kawaguchi-Sakita N; Kawashima M; Inagaki-Kawata Y; Yoshida K; Takada M; Kataoka M; Torii M; Nishimura T; Kawaguchi K; Suzuki E; Kataoka Y; Matsumoto Y; Yoshibayashi H; Yamagami K; Tsuyuki S; Takahara S; Yamauchi A; Shinkura N; Kato H; Moriguchi Y; Okamura R; Kan N; Suwa H; Sakata S; Mashima S; Yotsumoto F; Tachibana T; Tanaka M; Togashi K; Haga H; Yamada T; Kosugi S; Inamoto T; Sugimoto M; Ogawa S; Toi M
Cancer Sci; 2021 Aug; 112(8):3338-3348. PubMed ID: 34036661
[TBL] [Abstract][Full Text] [Related]
18. The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
Evans DG; van Veen EM; Byers H; Roberts E; Howell A; Howell SJ; Harkness EF; Brentnall A; Cuzick J; Newman WG
Int J Cancer; 2022 Jan; 150(1):73-79. PubMed ID: 34460111
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
